Worldwide opposition to vaccine mandates, booster shots every "x" months, negative test required upon arrival for travel. The unvaccinated have antibodies! One of the only stocks that benefits from calamity like this is QUIDEL. In short Quidel does everything related to covid testing including testing for antigens. At the start of the pandemic Quidel rose due to...
I sold my QDEL holdings after seeing the bearish reversal pattern, now opening a gap, it might go lower towards the bottom of the channel again. It is close to the channel midline, but I think the descending black trendline is the one to look for.
I will be entering again when I see strength, probably below $130 depending on the price action.
TRADE TYPE: Simple trade using the concept of parabolic corrections and zigzags. TIMELINE: 1-10 days. Look for double bottom at the end of zigzag to confirm end of correction and reversal to the long side.
QDEL is still bearish, but almost finished with a zig-zag correction of which it is now within the last wave of wave C. My target is the 84 dollar region since wave C is generally 1.618 the length of wave A.
Quidel: a manufacturer of diagnostic products, frequently rises or sinks in response to developments in the coronavirus pandemic, as a big part of their revenue comes from its COVID-19 testing kits.
As the Delta Variant is worrying countries around the globe, QDEL will be interesting to watch.
As you can see in the weekly ...
At long term 3 step ABC fib retracement levels (under 1.0) off all time high. This would be the fourth breakout, note the previous 3. RSI divergence as well, possible bottom. Starting to break out of bullish falling wedge. RSI pattern looks very similar to breakout 3. I am buying call options. MACD crossed over positive on 5/5 on daily chart, is still positive. I...
Named one of Investopedia's Top Growth Stocks for May 2021, QDEL offers a good buying opportunity even at current prices.
QDEL (www.wsj.com) has a low price target of $95 and a median price target of $167.
I would think this a great buy at $80-95 with a sell at $140, which is the current resistance before a pop...
"Quidel has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to market its Easy-to-use test that provides results in 15 minutes is now available without a prescription".
It has been growing dramatically as part of the pandemic, which is not surprising. What I see now. The paper is moving in a downward channel (highlighted in blue). In February it broke through the uptrend line that started in March 20. And now it is trading closer to the lower boundary of the channel.
The maximum that the paper can go down, I see at $104-$105....
Quidel (QDEL) is cheap for me now.
The market somewhat exaggerated its sale.
This company has a lot to offer even after the COVID crisis. Are there any other positive news and their balance sheet?
Research yourself, strong company!
Iam in at 125.5 and waitin for some good premium, expect a mild pump on Monday, but I'm waiting for at least a 50-100 %...
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide.
Why I'm buying right now:
Price target is from low 165.00 to high 341.00
2019 earnings - 72.92 M -> 2020 earnings -...
Quidel Corporation develops, manufactures and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases and toxicology worldwide.
The company during 2020 benefited greatly from the pandemic thanks to its Covid-19 QuickVue test that recently received FDA...